Kelly M. Brady
Chief Tech/Sci/R&D Officer at SERES THERAPEUTICS, INC.
Profile
Kelly M.
Brady is currently the Vice President-Clinical Operations at Seres Therapeutics, Inc. She previously worked as a Senior Director at Akebia Therapeutics, Inc. and as a Member-Operations Team at Osiris Therapeutics, Inc. Ms. Brady holds a graduate degree from The Johns Hopkins University and an undergraduate degree from Lafayette College.
Kelly M. Brady active positions
Companies | Position | Start |
---|---|---|
SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-05-31 |
Former positions of Kelly M. Brady
Companies | Position | End |
---|---|---|
AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Kelly M. Brady
The Johns Hopkins University | Graduate Degree |
Lafayette College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AKEBIA THERAPEUTICS, INC. | Health Technology |
SERES THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
- Stock Market
- Insiders
- Kelly M. Brady